BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng Q, Min S, Zhou Q. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases. Biosci Rep 2021;41:BSR20204370. [PMID: 34017995 DOI: 10.1042/BSR20204370] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Du H, Li B, Luo Z, Zhu L. Unlocking phenotypic plasticity provides novel insights for immunity and personalized therapy in lung adenocarcinoma. Front Genet 2022;13:941567. [DOI: 10.3389/fgene.2022.941567] [Reference Citation Analysis]
2 Li J, Gu X, Gao C, Zhang J, Sun Y. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma. Genetics Research 2022;2022:1-15. [DOI: 10.1155/2022/5955052] [Reference Citation Analysis]
3 Zhang M, Li J, Lin W, Qi L, Yao C, Zheng Z, Chen C, Duan S, Qi Y. EPAS1 Promoter Hypermethylation is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer. Genet Test Mol Biomarkers 2022. [PMID: 35920832 DOI: 10.1089/gtmb.2021.0305] [Reference Citation Analysis]
4 Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M, Bonavida B. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis. Antioxidants (Basel) 2022;11:1195. [PMID: 35740092 DOI: 10.3390/antiox11061195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhao R, Ding D, Ding Y, Han R, Wang X, Zhu C. Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes. Front Genet 2022;13:828543. [DOI: 10.3389/fgene.2022.828543] [Reference Citation Analysis]
6 Zhang Y, Liu Q, Cui M, Wang M, Hua S, Gao J, Liao Q. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma. Front Immunol 2021;12:774435. [PMID: 35046938 DOI: 10.3389/fimmu.2021.774435] [Reference Citation Analysis]
7 Li Y, Yu X, Zhang Y, Wang X, Zhao L, Liu D, Zhao G, Gao X, Fu J, Zang A, Jia Y. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis. Biomed Eng Online 2021;20:117. [PMID: 34819106 DOI: 10.1186/s12938-021-00952-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu X, Liu Y, Liu Z, Zhang Y, Ma Y, Bai J, Yao H, Wang Y, Zhao X, Li R, Song X, Chen Y, Feng Z, Wang L. Identification of SLITRK6 as a Novel Biomarker in hepatocellular carcinoma by comprehensive bioinformatic analysis. Biochem Biophys Rep 2021;28:101157. [PMID: 34754951 DOI: 10.1016/j.bbrep.2021.101157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]